Floatz logo

Iodine I 124 Monoclonal Antibody M5A

Colorectal Cancer

City of Hope Medical CenterradiopharmaceuticalPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

840 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Desflurane
Peter MacCallum Cancer Centre, Australia
Phase 4BBB
MARBLE DUST
James Varani
Phase 2/3BB
Orectalip
Sinphar Pharmaceutical Co., Ltd
Phase 4BB
Eloxatin
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 4BB
FLUOROURACILUM
UNICANCER
Phase 4BB

View all 50 →

Same molecule, other indications

Iodine I 124 Monoclonal Antibody M5A is also rated in:

metastasis from malignant tumor of colonDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →